W81XWH18Q01350001_Amendment.pdf

AMENDMENT OF SOLICITATION/MODIFICATION OF CONTRACT

Except as provided herein, all terms and conditions of the document referenced in Item 9A or 10A, as heretofore changed, remains unchanged and in full force and effect.

15A. NAME AND TITLE OF SIGNER (Type or print)

30-105-04EXCEPTION TO SF 30

APPROVED BY OIRM 11-84

STANDARD FORM 30 (Rev. 10-83) Prescribed by GSA

FAR (48 CFR) 53.243

The purpose of this amendment is to:

1. Incorporate revised performance w ork statement by reference.

2. Incorporate responses to questions.

1. CONTRACT ID CODE PAGE OF PAGES

S 1 5

16A. NAME AND TITLE OF CONTRACTING OFFICER (Type or print)

16C. DATE SIGNED

BY 28-Jun-2018

16B. UNITED STATES OF AMERICA15C. DATE SIGNED15B. CONTRACTOR/OFFEROR

(Signature of Contracting Officer)(Signature of person authorized to sign)

8. NAME AND ADDRESS OF CONTRACTOR (No., Street, County, State and Zip Code) X W81XWH18Q0135

X 9B. DATED (SEE ITEM 11)

04-Jun-2018

10B. DATED (SEE ITEM 13)

9A. AMENDMENT OF SOLICITATION NO.

11. THIS ITEM ONLY APPLIES TO AMENDMENTS OF SOLICITATIONS

X The above numbered solicitation is amended as set forth in Item 14. The hour and date specified for receipt of Offer is extended, X is not extended.

Offer must acknowledge receipt of this amendment prior to the hour and date specified in the solicitation or as amended by one of the following methods:

(a) By completing Items 8 and 15, and returning 1 copies of the amendment; (b) By acknowledging receipt of this amendment on each copy of the offer submitted;

or (c) By separate letter or telegram which includes a reference to the solicitation and amendment numbers. FAILURE OF YOUR ACKNOWLEDGMENT TO BE RECEIVED AT THE PLACE DESIGNATED FOR THE RECEIPT OF OFFERS PRIOR TO THE HOUR AND DATE SPECIFIED MAY RESULT IN REJECTION OF YOUR OFFER. If by virtue of this amendment you desire to change an offer already submitted, such change may be made by telegram or letter, provided each telegram or letter makes reference to the solicitation and this amendment, and is received prior to the opening hour and date specified.

12. ACCOUNTING AND APPROPRIATION DATA (If required)

13. THIS ITEM APPLIES ONLY TO MODIFICATIONS OF CONTRACTS/ORDERS.

IT MODIFIES THE CONTRACT/ORDER NO. AS DESCRIBED IN ITEM 14.

A. THIS CHANGE ORDER IS ISSUED PURSUANT TO: (Specify authority) THE CHANGES SET FORTH IN ITEM 14 ARE MADE IN THE

CONTRACT ORDER NO. IN ITEM 10A.

B. THE ABOVE NUMBERED CONTRACT/ORDER IS MODIFIED TO REFLECT THE ADMINISTRATIVE CHANGES (such as changes in paying office, appropriation date, etc.) SET FORTH IN ITEM 14, PURSUANT TO THE AUTHORITY OF FAR 43.103(B).

C. THIS SUPPLEMENTAL AGREEMENT IS ENTERED INTO PURSUANT TO AUTHORITY OF:

D. OTHER (Specify type of modification and authority)

E. IMPORTANT: Contractor is not, is required to sign this document and return copies to the issuing office.

14. DESCRIPTION OF AMENDMENT/MODIFICATION (Organized by UCF section headings, including solicitation/contract subject matter where feasible.)

10A. MOD. OF CONTRACT/ORDER NO.

2. AMENDMENT/MODIFICATION NO. 5. PROJECT NO.(If applicable)

6. ISSUED BY

3. EFFECTIVE DATE

28-Jun-2018

CODE

US ARMY MEDICAL RESEARCH ACQUISITION ACT

DIRECTOR

820 CHANDLER STREET

FORT DETRICK MD 21702-5014

W81XWH 7. ADMINISTERED BY (If other than item 6)

4. REQUISITION/PURCHASE REQ. NO.

CODE

See Item 6

FACILITY CODECODE

EMAIL:TEL:

W81XWH18Q0135

SECTION SF 30 BLOCK 14 CONTINUATION PAGE

SUMMARY OF CHANGES

SECTION SF 1449 - CONTINUATION SHEET

SUPPLIES OR SERVICES AND PRICES

CLIN 0002

The CLIN extended description has changed from:

Other Direct Cost include Material and Supplies, Equipment and Travel. The following plug number $143,460.00 is being provided for other direct cost. All offerors are to use this number for their response.

To:

Other Direct Cost include material and supplies, equipment, travel, sample analysis, QC, data confirmation and training support. The following plug number $343,460.00 is being provided for other direct cost. All offerors are to use this number for their response.

CLIN 1002

Other Direct Cost include Material and Supplies, Equipment and Other Direct Cost include Material and Supplies, Equipment and Travel. The following plug number $144,764.00 is being provided for other direct cost. All offerors are to use this number for their response.

Other Direct Cost include material and supplies, equipment and travel, sample analysis, QC, data confirmation and training support. The following plug number $343,764.00 is being provided for other direct cost. All offerors are to

CLIN 2002

Other Direct Cost include Material and Supplies, Equipment and Travel. The following plug number $146,107.00 is

Other Direct Cost include material and supplies, equipment, travel, sample analysis, QC, data confirmation and training support. The following plug number $346,107.00 is being provided for other direct cost. All offerors are to

CLIN 3002

Other Direct Cost include Material and Supplies, Equipment and Travel. The following plug number $147,490.00 is

Other Direct Cost include material and supplies, equipment, travel, sample analysis, QC, data confirmation and training support. The following plug number $347,490.00 is being provided for other direct cost. All offerors are to

CLIN 4002

Other Direct Cost include Material and Supplies, Equipment and Travel. The following plug number $148,915.00 is

Other Direct Cost include material and supplies, equipment, travel, sample analysis, QC, data confirmation and training support. The following plug number $348,915.00 is being provided for other direct cost. All offerors are to

CLIN 4003

The option status has changed from No Status to Option.

TABLE OF CONTENTS

The Table of Contents has changed from:

Exhibit/Attachment Table of Contents

DOCUMENT TYPE DESCRIPTION PAGES DATE

Attachment 1 Attachment 1 PWS 17-MAY-2018 Attachment 2 Attachment 2 QASP 17-MAY-2018 to:

Exhibit/Attachment Table of Contents

DOCUMENT TYPE DESCRIPTION PAGES DATE

Attachment 1 Attachment 1 PWS 28-JUN-2018

The following have been added by full text:

QUESTIONS AND RESPONSE

1. Solicitation page 18 states “Each file of the proposal shall contain a … Summary Section.” Please confirm the 1-page Executive Summary/Abstract is required for the Business Proposal, Technical Approach, and Past Performance volumes.

ANS: The 1-page Executive Summary/Abstract is not required for all volumes only Volume 1

2. Is the 1-page Executive Summary/Abstract included in the 30-page limitation on the Technical Approach volume?

ANS: The 1-page Executive Summary/Abstract is not included in the 30-page limitation on the Technical Approach volume.

3. In PWS Section 4-Period of Performance, the table lists 2022 as the end date for Option Period 4. Please confirm the end date for Option Period 4 should be September 17, 2023.

ANS: The period of performance will end on September 17, 2023. An amendment will be completed to reflect the change

4. Is there a current incumbent for this work?

ANS: Yes

5. If there is an incumbent, would a new contractor be expected to retain any of the current project staff?

ANS: Yes, there are current project staff that are expected to be retained on the new contract.

6. May offerors submit cooperative agreements as past performance references?

ANS: Offers are to submit past performance references in accordance with the instructions in the RFQ.

7. PWS Section 13-Subcontracting lists an allotted amount of up to $200,000 per year for subcontracting. Is this a total limit on subcontracting or is it per subcontractor?

ANS: Please see the revised PWS and the RFQ.

8. If an offeror proposes an approach utilizing partners/subcontractors based outside of Cambodia, are those subcontracts limited to $200,000 per year?

9. Could the government provide more information on what tasks should be included in the $200,000 for subcontracting?

10. How many clinical trials are currently supported by this contract?

ANS: Currently there are 5 clinical trials that are supported by the current contract, and all will require continued support under the new contract.

11. How many clinical trials are anticipated to be supported by this contract annually?

ANS: Typically, 4 to 6 clinical studies will be supported under this contract.

12. PWS Section 8.1(j) notes the transfer of GFE which contradicts PWS Section 12. Please verify if GFE will be transferred for this program. IF GFE is being transferred can you provide this inventory?

ANS: No GFE will be transferred upon initial award, but it is anticipated that GFE may be transferred at a later date to support study technical execution (i.e. blood analyzers, freezers, etc).

13. Will the Government consider extending the due date for the solicitation?

ANS: No the solicitation will not be extended.

(End of Summary of Changes)